{"transactions":[{"id":683655,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-08-18T21:51:24.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":2230,"price":1.93,"value":4303.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2026."}],"balance_after":294379,"source":{"system":"sec-edgar","filing":"0001193125-26-355764","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526355764/ownership.xml","form_type":"4"}},{"id":683654,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Wong Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2026-08-18T21:50:21.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":573,"price":1.93,"value":1105.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":87828,"source":{"system":"sec-edgar","filing":"0001193125-26-355761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526355761/ownership.xml","form_type":"4"}},{"id":715403,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Wong Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2026-07-06T20:30:22.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":1404,"price":2.04,"value":2864.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2026."}],"balance_after":88401,"source":{"system":"sec-edgar","filing":"0001193125-26-296246","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526296246/ownership.xml","form_type":"4"}},{"id":805725,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":52060,"kind":"person","name":"Knight Jeff E.","position":1,"cik":"0001881007","reported_name":"Knight Jeff E.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Dev & Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-04-17T20:15:03.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":800000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option vest on April 13, 2027 and 1/48th vest monthly thereafter."}],"balance_after":800000,"derivative":{"exercise_price":1.68,"expiration_date":"2036-04-15","underlying":"Common Stock","underlying_shares":800000},"source":{"system":"sec-edgar","filing":"0001193125-26-161558","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526161558/ownership.xml","form_type":"4"}},{"id":805724,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":31402,"kind":"person","name":"Klencke Barbara","position":1,"cik":"0001647647","reported_name":"Klencke Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-04-17T20:15:02.000Z","date":"2026-04-16","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option vest on February 25, 2027 and 1/48th vest monthly thereafter."}],"balance_after":100000,"derivative":{"exercise_price":1.68,"expiration_date":"2036-04-15","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-161557","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526161557/ownership.xml","form_type":"4"}},{"id":830857,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-03-23T20:05:08.000Z","date":"2026-03-19","kind":"sale","planned":false,"acquired":false,"shares":12311,"price":2.17,"value":26714.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of perfomance-based restricted stock units."}],"balance_after":293609,"source":{"system":"sec-edgar","filing":"0001193125-26-119705","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526119705/ownership.xml","form_type":"4"}},{"id":830856,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2026-03-23T20:05:04.000Z","date":"2026-03-19","kind":"sale","planned":false,"acquired":false,"shares":903,"price":2.17,"value":1959.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of perfomance-based restricted stock units."}],"balance_after":86805,"source":{"system":"sec-edgar","filing":"0001193125-26-119703","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526119703/ownership.xml","form_type":"4"}},{"id":858728,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":31402,"kind":"person","name":"Klencke Barbara","position":1,"cik":"0001647647","reported_name":"Klencke Barbara","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-03-05T21:05:06.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":700000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option vest on February 25, 2027 and 1/48th vest monthly thereafter."}],"balance_after":700000,"derivative":{"exercise_price":2.07,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":700000},"source":{"system":"sec-edgar","filing":"0001193125-26-093913","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526093913/ownership.xml","form_type":"4"}},{"id":890790,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2026-02-20T21:01:02.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":565,"price":2.27,"value":1282.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":87708,"source":{"system":"sec-edgar","filing":"0001193125-26-061313","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526061313/ownership.xml","form_type":"4"}},{"id":893521,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2026-02-20T02:02:25.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2201,"price":2.27,"value":4996.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2025."}],"balance_after":305920,"source":{"system":"sec-edgar","filing":"0001193125-26-060037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526060037/ownership.xml","form_type":"4"}},{"id":919526,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":17062,"kind":"person","name":"GOODMAN COREY S","position":1,"cik":"0001278411","reported_name":"GOODMAN COREY S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-04T21:15:59.000Z","date":"2026-02-02","kind":"purchase","planned":false,"acquired":true,"shares":3184713,"price":1.57,"value":4999999.41,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The shares are held of record by venBio Global Strategic Fund II, L.P. venBio Global Strategic GP II, LP is the sole general partner of venBio Global Strategic Fund II, LP and venBio Global Strategic GP II, Ltd. is the sole general partner of venBio Global Strategic GP II, L.P. The reporting person, a director of venBio Global Strategic GP II, Ltd., disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein."}],"balance_after":8453038,"source":{"system":"sec-edgar","filing":"0001278411-26-000002","document":"form4-02042026_090252.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000127841126000002/form4-02042026_090252.xml","form_type":"4"}},{"id":929046,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Stock option (right to buy)","published_at":"2026-01-28T21:30:09.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":192000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on February 26, 2026."}],"balance_after":192000,"derivative":{"exercise_price":1.48,"expiration_date":"2036-01-25","underlying":"Common Stock","underlying_shares":192000},"source":{"system":"sec-edgar","filing":"0001193125-26-027288","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526027288/ownership.xml","form_type":"4"}},{"id":929045,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Stock option (right to buy)","published_at":"2026-01-28T21:30:02.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":912000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on February 26, 2026."}],"balance_after":912000,"derivative":{"exercise_price":1.48,"expiration_date":"2036-01-25","underlying":"Common Stock","underlying_shares":912000},"source":{"system":"sec-edgar","filing":"0001193125-26-027287","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526027287/ownership.xml","form_type":"4"}},{"id":929122,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":68609,"kind":"person","name":"Shantharam Harish","position":1,"cik":"0001976391","reported_name":"Shantharam Harish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-01-28T16:30:12.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":303000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on February 26, 2026."}],"balance_after":303000,"derivative":{"exercise_price":1.48,"expiration_date":"2036-01-25","underlying":"Common Stock","underlying_shares":303000},"source":{"system":"sec-edgar","filing":"0001193125-26-027290","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1976391/000119312526027290/ownership.xml","form_type":"4"}},{"id":934339,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":17062,"kind":"person","name":"GOODMAN COREY S","position":1,"cik":"0001278411","reported_name":"GOODMAN COREY S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-21T21:30:35.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026."}],"balance_after":40400,"derivative":{"exercise_price":1.32,"expiration_date":"2036-01-19","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001193125-26-018039","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526018039/ownership.xml","form_type":"4"}},{"id":934337,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":35913,"kind":"person","name":"Garland J. Scott","position":1,"cik":"0001533228","reported_name":"Garland J. Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-21T21:30:32.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026."}],"balance_after":40400,"derivative":{"exercise_price":1.32,"expiration_date":"2036-01-19","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001193125-26-018037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526018037/ownership.xml","form_type":"4"}},{"id":934338,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":55791,"kind":"person","name":"Sandler Alan B.","position":1,"cik":"0001835966","reported_name":"Sandler Alan B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-21T21:30:17.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":10100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026."}],"balance_after":10100,"derivative":{"exercise_price":1.32,"expiration_date":"2036-01-19","underlying":"Common Stock","underlying_shares":10100},"source":{"system":"sec-edgar","filing":"0001193125-26-018028","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526018028/ownership.xml","form_type":"4"}},{"id":934336,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":29714,"kind":"person","name":"Curran Daniel J.","position":1,"cik":"0001887599","reported_name":"Curran Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-21T21:30:06.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":16833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026."}],"balance_after":16833,"derivative":{"exercise_price":1.32,"expiration_date":"2036-01-19","underlying":"Common Stock","underlying_shares":16833},"source":{"system":"sec-edgar","filing":"0001193125-26-018023","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526018023/ownership.xml","form_type":"4"}},{"id":934334,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-21T21:30:05.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026."}],"balance_after":40400,"derivative":{"exercise_price":1.32,"expiration_date":"2036-01-19","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001193125-26-018022","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526018022/ownership.xml","form_type":"4"}},{"id":934335,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-01-21T21:30:03.000Z","date":"2026-01-20","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026."}],"balance_after":40400,"derivative":{"exercise_price":1.32,"expiration_date":"2036-01-19","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001193125-26-018021","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526018021/ownership.xml","form_type":"4"}},{"id":944596,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2026-01-07T21:30:06.000Z","date":"2026-01-06","kind":"sale","planned":false,"acquired":false,"shares":3925,"price":1.11,"value":4356.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.11 to $1.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2025."}],"balance_after":88273,"source":{"system":"sec-edgar","filing":"0001193125-26-006374","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526006374/ownership.xml","form_type":"4"}},{"id":1017644,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-16T20:01:07.000Z","date":"2025-10-14","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option vest on April 30, 2026 and the remaining two-thirds of the option vest on October 31, 2026."}],"balance_after":140000,"derivative":{"exercise_price":1.7,"expiration_date":"2035-10-14","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001193125-25-241382","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312525241382/ownership.xml","form_type":"4"}},{"id":1017642,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-16T20:01:06.000Z","date":"2025-10-14","kind":"grant","planned":false,"acquired":true,"shares":597500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option vest on April 30, 2026 and the remaining two-thirds of the option vest on October 31, 2026."}],"balance_after":597500,"derivative":{"exercise_price":1.7,"expiration_date":"2035-10-14","underlying":"Common Stock","underlying_shares":597500},"source":{"system":"sec-edgar","filing":"0001193125-25-241381","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312525241381/ownership.xml","form_type":"4"}},{"id":1017696,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":68609,"kind":"person","name":"Shantharam Harish","position":1,"cik":"0001976391","reported_name":"Shantharam Harish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-16T16:01:03.000Z","date":"2025-10-14","kind":"grant","planned":false,"acquired":true,"shares":198750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option vest on April 30, 2026 and the remaining two-thirds of the option vest on October 31, 2026."}],"balance_after":198750,"derivative":{"exercise_price":1.7,"expiration_date":"2035-10-14","underlying":"Common Stock","underlying_shares":198750},"source":{"system":"sec-edgar","filing":"0001193125-25-241380","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1976391/000119312525241380/ownership.xml","form_type":"4"}},{"id":1035632,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":31402,"kind":"person","name":"Klencke Barbara","position":1,"cik":"0001647647","reported_name":"Klencke Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-09-19T20:01:03.000Z","date":"2025-09-17","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option vest on each of September 17, 2025, January 31, 2026 and June 30, 2026."}],"balance_after":300000,"derivative":{"exercise_price":1.05,"expiration_date":"2035-09-16","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001193125-25-209045","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312525209045/ownership.xml","form_type":"4"}},{"id":1036390,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-09-18T20:23:19.000Z","date":"2025-09-17","kind":"purchase","planned":false,"acquired":true,"shares":71163,"price":1.0805,"value":76891.6215,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.09, inclusive."}],"balance_after":305121,"source":{"system":"sec-edgar","filing":"0001193125-25-207432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312525207432/ownership.xml","form_type":"4"}},{"id":1036389,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-09-18T20:23:19.000Z","date":"2025-09-16","kind":"purchase","planned":false,"acquired":true,"shares":21070,"price":1.066,"value":22460.62,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4."}],"balance_after":233958,"source":{"system":"sec-edgar","filing":"0001193125-25-207432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000119312525207432/ownership.xml","form_type":"4"}},{"id":1060448,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":68609,"kind":"person","name":"Shantharam Harish","position":1,"cik":"0001976391","reported_name":"Shantharam Harish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-08-20T16:02:05.000Z","date":"2025-08-18","kind":"purchase","planned":false,"acquired":true,"shares":75000,"price":0.7787,"value":58402.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6823 to $0.9234, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0000950170-25-110434","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1976391/000095017025110434/ownership.xml","form_type":"4"}},{"id":1061947,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2025-08-19T20:12:34.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":611,"price":0.6404,"value":391.2844,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.64 to $0.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2025."}],"balance_after":89198,"source":{"system":"sec-edgar","filing":"0000950170-25-110102","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000095017025110102/ownership.xml","form_type":"4"}},{"id":1061945,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-08-19T20:09:59.000Z","date":"2025-08-15","kind":"sale","planned":false,"acquired":false,"shares":2382,"price":0.6404,"value":1525.4328,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.64 to $0.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2025."}],"balance_after":212888,"source":{"system":"sec-edgar","filing":"0000950170-25-110099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000095017025110099/ownership.xml","form_type":"4"}},{"id":1067868,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":29714,"kind":"person","name":"Curran Daniel J.","position":1,"cik":"0001887599","reported_name":"Curran Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-08-13T20:47:50.000Z","date":"2025-08-12","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 36 equal monthly installments beginning on September 12, 2025."}],"balance_after":40400,"derivative":{"exercise_price":0.615,"expiration_date":"2035-08-11","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0000950170-25-108119","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000095017025108119/ownership.xml","form_type":"4"}},{"id":1090685,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2025-07-08T20:37:37.000Z","date":"2025-07-07","kind":"sale","planned":false,"acquired":false,"shares":2011,"price":0.4501,"value":905.1511,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.45 to $0.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":86809,"source":{"system":"sec-edgar","filing":"0000950170-25-094613","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000095017025094613/ownership.xml","form_type":"4"}},{"id":1097971,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2025-07-01T20:22:14.000Z","date":"2025-06-30","kind":"sale","planned":false,"acquired":false,"shares":1532,"price":0.43,"value":658.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":88820,"source":{"system":"sec-edgar","filing":"0000950170-25-092232","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000095017025092232/ownership.xml","form_type":"4"}},{"id":1171875,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-15T20:29:19.000Z","date":"2025-04-11","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to the option vest on April 11, 2026."}],"balance_after":90000,"derivative":{"exercise_price":0.49,"expiration_date":"2035-04-11","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001415889-25-010697","document":"form4-04152025_080416.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925010697/form4-04152025_080416.xml","form_type":"4"}},{"id":1171874,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":55791,"kind":"person","name":"Sandler Alan B.","position":1,"cik":"0001835966","reported_name":"Sandler Alan B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-15T20:19:34.000Z","date":"2025-04-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to the option vest on April 11, 2026."}],"balance_after":125000,"derivative":{"exercise_price":0.49,"expiration_date":"2035-04-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-25-010692","document":"form4-04152025_080430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925010692/form4-04152025_080430.xml","form_type":"4"}},{"id":1171871,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-15T20:14:02.000Z","date":"2025-04-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to the option vest on April 11, 2026."}],"balance_after":125000,"derivative":{"exercise_price":0.49,"expiration_date":"2035-04-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-25-010686","document":"form4-04152025_080459.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925010686/form4-04152025_080459.xml","form_type":"4"}},{"id":1171922,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":68609,"kind":"person","name":"Shantharam Harish","position":1,"cik":"0001976391","reported_name":"Shantharam Harish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-04-15T16:16:28.000Z","date":"2025-04-11","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"All of the shares subject to the option vest on April 11, 2026."}],"balance_after":125000,"derivative":{"exercise_price":0.49,"expiration_date":"2035-04-11","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-25-010690","document":"form4-04152025_080423.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1976391/000141588925010690/form4-04152025_080423.xml","form_type":"4"}},{"id":1200157,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2025-03-18T20:45:00.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics related to the positive results for ASPEN-06 clinical trials. Shares subject to the PSU vest on March 14, 2026."}],"balance_after":90352,"source":{"system":"sec-edgar","filing":"0001415889-25-008428","document":"form4-03182025_080356.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925008428/form4-03182025_080356.xml","form_type":"4"}},{"id":1200156,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-03-18T20:41:30.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":42000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics related to the positive results for ASPEN-06 clinical trials. Shares subject to the PSU vest on March 14, 2026."}],"balance_after":212270,"source":{"system":"sec-edgar","filing":"0001415889-25-008417","document":"form4-03182025_080326.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925008417/form4-03182025_080326.xml","form_type":"4"}},{"id":1253104,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2025-02-21T21:25:30.000Z","date":"2025-02-19","kind":"sale","planned":false,"acquired":false,"shares":550,"price":1.1502,"value":632.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":87352,"source":{"system":"sec-edgar","filing":"0001415889-25-005071","document":"form4-02212025_090224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925005071/form4-02212025_090224.xml","form_type":"4"}},{"id":1253105,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2025-02-21T21:20:19.000Z","date":"2025-02-19","kind":"sale","planned":false,"acquired":false,"shares":2159,"price":1.1502,"value":2483.2818,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2024."}],"balance_after":170270,"source":{"system":"sec-edgar","filing":"0001415889-25-005067","document":"form4-02212025_090215.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925005067/form4-02212025_090215.xml","form_type":"4"}},{"id":1253126,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2025-02-21T16:23:12.000Z","date":"2025-02-19","kind":"sale","planned":false,"acquired":false,"shares":1326,"price":1.1502,"value":1525.1652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":579388,"source":{"system":"sec-edgar","filing":"0001415889-25-005069","document":"form4-02212025_090208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588925005069/form4-02212025_090208.xml","form_type":"4"}},{"id":1296461,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T23:32:49.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 21, 2025."}],"balance_after":40400,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001415889-25-001983","document":"form4-01232025_110145.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925001983/form4-01232025_110145.xml","form_type":"4"}},{"id":1296460,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":35913,"kind":"person","name":"Garland J. Scott","position":1,"cik":"0001533228","reported_name":"Garland J. Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-23T23:30:52.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 21, 2025."}],"balance_after":40400,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001415889-25-001981","document":"form4-01232025_110148.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925001981/form4-01232025_110148.xml","form_type":"4"}},{"id":1296459,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":17062,"kind":"person","name":"GOODMAN COREY S","position":1,"cik":"0001278411","reported_name":"GOODMAN COREY S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T23:29:17.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments beginning on February 21, 2025."}],"balance_after":40400,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001415889-25-001979","document":"form4-01232025_110113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925001979/form4-01232025_110113.xml","form_type":"4"}},{"id":1296458,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":69059,"kind":"person","name":"Takimoto Chris H","position":1,"cik":"0001743780","reported_name":"Takimoto Chris H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock (right to buy)","published_at":"2025-01-23T23:27:39.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 36 equal monthly installments beginning on February 21, 2025."}],"balance_after":40400,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001415889-25-001977","document":"form4-01232025_110135.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925001977/form4-01232025_110135.xml","form_type":"4"}},{"id":1296457,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":31402,"kind":"person","name":"Klencke Barbara","position":1,"cik":"0001647647","reported_name":"Klencke Barbara","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T23:24:29.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 36 equal monthly installments beginning on February 21, 2025."}],"balance_after":40400,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001415889-25-001973","document":"form4-01232025_110125.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925001973/form4-01232025_110125.xml","form_type":"4"}},{"id":1296456,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-23T23:14:16.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on February 21, 2025."}],"balance_after":112000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001415889-25-001965","document":"form4-01232025_110113.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925001965/form4-01232025_110113.xml","form_type":"4"}},{"id":1296454,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":55791,"kind":"person","name":"Sandler Alan B.","position":1,"cik":"0001835966","reported_name":"Sandler Alan B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-23T23:11:49.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on February 21, 2025."}],"balance_after":100000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-25-001963","document":"form4-01232025_110146.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925001963/form4-01232025_110146.xml","form_type":"4"}},{"id":1296453,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-23T23:07:03.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":478000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on February 21, 2025."}],"balance_after":478000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":478000},"source":{"system":"sec-edgar","filing":"0001415889-25-001959","document":"form4-01232025_110159.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925001959/form4-01232025_110159.xml","form_type":"4"}},{"id":1296568,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":68609,"kind":"person","name":"Shantharam Harish","position":1,"cik":"0001976391","reported_name":"Shantharam Harish","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-23T18:19:33.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option vest on January 21, 2026 and 1/48 of the shares vest monthly thereafter."}],"balance_after":600000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001415889-25-001969","document":"form4-01232025_110129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1976391/000141588925001969/form4-01232025_110129.xml","form_type":"4"}},{"id":1296468,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-01-23T18:09:37.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 48 equal monthly installments beginning on February 21, 2025."}],"balance_after":50000,"derivative":{"exercise_price":1.65,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001415889-25-001961","document":"form4-01232025_110133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588925001961/form4-01232025_110133.xml","form_type":"4"}},{"id":1306755,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2025-01-08T21:10:48.000Z","date":"2025-01-06","kind":"sale","planned":false,"acquired":false,"shares":2221,"price":1.8,"value":3997.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.79 to $1.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":87902,"source":{"system":"sec-edgar","filing":"0001415889-25-001120","document":"form4-01082025_090144.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925001120/form4-01082025_090144.xml","form_type":"4"}},{"id":1318749,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2025-01-02T21:46:36.000Z","date":"2024-12-30","kind":"sale","planned":false,"acquired":false,"shares":1426,"price":1.5802,"value":2253.3652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.58 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":90123,"source":{"system":"sec-edgar","filing":"0001415889-25-000132","document":"form4-01022025_090133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588925000132/form4-01022025_090133.xml","form_type":"4"}},{"id":1318764,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2025-01-02T16:43:28.000Z","date":"2024-12-30","kind":"sale","planned":false,"acquired":false,"shares":10796,"price":1.5802,"value":17059.8392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.58 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":580714,"source":{"system":"sec-edgar","filing":"0001415889-25-000123","document":"form4-01022025_090125.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588925000123/form4-01022025_090125.xml","form_type":"4"}},{"id":1343122,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-04T21:17:28.000Z","date":"2024-12-02","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":1.5468,"value":46404.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.515 to $1.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001415889-24-028247","document":"form4-12042024_091224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924028247/form4-12042024_091224.xml","form_type":"4"}},{"id":1343121,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-04T21:15:29.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 30 equal monthly installments beginning on January 2, 2025."}],"balance_after":150000,"derivative":{"exercise_price":1.66,"expiration_date":"2031-12-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001415889-24-028245","document":"form4-12042024_091224.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924028245/form4-12042024_091224.xml","form_type":"4"}},{"id":1343120,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-04T21:13:02.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 30 equal monthly installments beginning on January 2, 2025."}],"balance_after":200000,"derivative":{"exercise_price":1.66,"expiration_date":"2031-12-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-24-028239","document":"form4-12042024_091258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924028239/form4-12042024_091258.xml","form_type":"4"}},{"id":1359379,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":55791,"kind":"person","name":"Sandler Alan B.","position":1,"cik":"0001835966","reported_name":"Sandler Alan B.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-11-19T21:05:47.000Z","date":"2024-11-18","kind":"grant","planned":false,"acquired":true,"shares":600000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of the shares subject to the option vest on November 18, 2025 and 1/48th of the shares vest monthly thereafter."}],"balance_after":600000,"derivative":{"exercise_price":1.22,"expiration_date":"2034-11-17","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001415889-24-027181","document":"form4-11192024_091142.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924027181/form4-11192024_091142.xml","form_type":"4"}},{"id":1431432,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2024-08-16T21:10:39.000Z","date":"2024-08-14","kind":"sale","planned":false,"acquired":false,"shares":564,"price":2.58,"value":1455.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":91549,"source":{"system":"sec-edgar","filing":"0001415889-24-021482","document":"form4-08162024_090836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924021482/form4-08162024_090836.xml","form_type":"4"}},{"id":1431431,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-08-16T21:08:10.000Z","date":"2024-08-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":761,"price":2.58,"value":1963.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":121516,"source":{"system":"sec-edgar","filing":"0001415889-24-021476","document":"form4-08162024_090807.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924021476/form4-08162024_090807.xml","form_type":"4"}},{"id":1431428,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-08-16T21:05:34.000Z","date":"2024-08-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2191,"price":2.58,"value":5652.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs."}],"balance_after":169429,"source":{"system":"sec-edgar","filing":"0001415889-24-021471","document":"form4-08162024_090831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924021471/form4-08162024_090831.xml","form_type":"4"}},{"id":1431437,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":88253,"kind":"person","name":"Randolph Sophia","position":1,"cik":"0001817127","reported_name":"Randolph Sophia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-08-16T17:09:26.000Z","date":"2024-08-14","kind":"sale","planned":false,"acquired":false,"shares":1365,"price":2.58,"value":3521.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":325711,"source":{"system":"sec-edgar","filing":"0001415889-24-021480","document":"form4-08162024_090823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817127/000141588924021480/form4-08162024_090823.xml","form_type":"4"}},{"id":1431436,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2024-08-16T17:06:49.000Z","date":"2024-08-14","kind":"sale","planned":false,"acquired":false,"shares":1937,"price":2.58,"value":4997.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."}],"balance_after":591510,"source":{"system":"sec-edgar","filing":"0001415889-24-021474","document":"form4-08162024_090846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924021474/form4-08162024_090846.xml","form_type":"4"}},{"id":1438856,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":55791,"kind":"person","name":"Sandler Alan B.","position":1,"cik":"0001835966","reported_name":"Sandler Alan B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-07T21:23:49.000Z","date":"2024-08-05","kind":"grant","planned":false,"acquired":true,"shares":40400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 36 equal monthly installments beginning on September 5, 2024."}],"balance_after":40400,"derivative":{"exercise_price":2.73,"expiration_date":"2034-08-04","underlying":"Common Stock","underlying_shares":40400},"source":{"system":"sec-edgar","filing":"0001415889-24-020932","document":"form4-08072024_090845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924020932/form4-08072024_090845.xml","form_type":"4"}},{"id":1454646,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-07-15T16:06:25.000Z","date":"2024-07-11","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":144433,"derivative":{"exercise_price":0.99,"expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-019546","document":"form4-07152024_080721.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924019546/form4-07152024_080721.xml","form_type":"4"}},{"id":1454645,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2024-07-15T16:06:25.000Z","date":"2024-07-11","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":7.9038,"value":158076.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.90 to 7.905, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":593447,"source":{"system":"sec-edgar","filing":"0001415889-24-019546","document":"form4-07152024_080721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924019546/form4-07152024_080721.xml","form_type":"4"}},{"id":1454644,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2024-07-15T16:06:25.000Z","date":"2024-07-11","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0.99,"value":19800.0,"ownership":{"direct":true},"balance_after":613447,"source":{"system":"sec-edgar","filing":"0001415889-24-019546","document":"form4-07152024_080721.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924019546/form4-07152024_080721.xml","form_type":"4"}},{"id":1457640,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2024-07-09T20:09:41.000Z","date":"2024-07-05","kind":"sale","planned":false,"acquired":false,"shares":1823,"price":5.4993,"value":10025.2239,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.45 to $5.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":92113,"source":{"system":"sec-edgar","filing":"0001415889-24-019429","document":"form4-07092024_080737.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924019429/form4-07092024_080737.xml","form_type":"4"}},{"id":1460181,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2024-07-03T21:03:25.000Z","date":"2024-07-01","kind":"sale","planned":false,"acquired":false,"shares":1373,"price":5.8188,"value":7989.2124,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.77 to $5.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,718 shares acquired under the Issuer's employee stock purchase plan on June 28, 2024."}],"balance_after":93936,"source":{"system":"sec-edgar","filing":"0001415889-24-019228","document":"form4-07032024_090722.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924019228/form4-07032024_090722.xml","form_type":"4"}},{"id":1460197,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":88253,"kind":"person","name":"Randolph Sophia","position":1,"cik":"0001817127","reported_name":"Randolph Sophia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-03T17:02:03.000Z","date":"2024-07-01","kind":"sale","planned":false,"acquired":false,"shares":3273,"price":5.8188,"value":19044.9324,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":327076,"source":{"system":"sec-edgar","filing":"0001415889-24-019224","document":"form4-07032024_090700.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817127/000141588924019224/form4-07032024_090700.xml","form_type":"4"}},{"id":1460196,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2024-07-03T17:00:28.000Z","date":"2024-07-01","kind":"sale","planned":false,"acquired":false,"shares":10758,"price":5.8188,"value":62598.6504,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":593447,"source":{"system":"sec-edgar","filing":"0001415889-24-019221","document":"form4-07032024_090724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924019221/form4-07032024_090724.xml","form_type":"4"}},{"id":1463220,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-02T20:39:44.000Z","date":"2024-06-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":1789,"price":6.03,"value":10787.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,718 shares acquired under the Issuer's employee stock purchase plan on June 28, 2024."}],"balance_after":122277,"source":{"system":"sec-edgar","filing":"0001415889-24-018919","document":"form4-07022024_080741.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924018919/form4-07022024_080741.xml","form_type":"4"}},{"id":1470754,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-24T13:00:55.000Z","date":"2024-06-13","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":8.5282,"value":102338.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"For purposes of the short-swing profit recovery provisions of Section 16(b) of the Securities Exchange Act of 1934, the acquisition of shares reported herein may be deemed to be matchable to the extent of 1,893 shares with the reporting person's sale of 1,893 shares of Issuer common stock to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units on December 29, 2023. The reporting person has agreed to pay to the Issuer $11,959.88, which represents the full amount of the profit realized in connection with the short-swing transaction, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4113 to $8.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":122348,"source":{"system":"sec-edgar","filing":"0001415889-24-017899","document":"form4a-06242024_010651.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924017899/form4a-06242024_010651.xml","form_type":"4/A","original_submission_date":"2024-06-17"}},{"id":1477414,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-06-17T11:29:53.000Z","date":"2024-06-13","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":8.5282,"value":102338.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.4113 to $8.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":122348,"source":{"system":"sec-edgar","filing":"0001415889-24-017054","document":"form4-06172024_110650.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924017054/form4-06172024_110650.xml","form_type":"4"}},{"id":1479176,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":36308,"kind":"person","name":"Hemrajani Rekha","position":1,"cik":"0001771213","reported_name":"Hemrajani Rekha","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:49:42.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":20200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments on the 13th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders."}],"balance_after":20200,"derivative":{"exercise_price":8.44,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":20200},"source":{"system":"sec-edgar","filing":"0001415889-24-016955","document":"form4-06142024_080638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924016955/form4-06142024_080638.xml","form_type":"4"}},{"id":1479175,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":35913,"kind":"person","name":"Garland J. Scott","position":1,"cik":"0001533228","reported_name":"Garland J. Scott","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:46:46.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":20200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments on the 13th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders."}],"balance_after":20200,"derivative":{"exercise_price":8.44,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":20200},"source":{"system":"sec-edgar","filing":"0001415889-24-016952","document":"form4-06142024_080642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924016952/form4-06142024_080642.xml","form_type":"4"}},{"id":1479174,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":17062,"kind":"person","name":"GOODMAN COREY S","position":1,"cik":"0001278411","reported_name":"GOODMAN COREY S","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-14T20:42:40.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":20200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 12 equal monthly installments on the 13th day of the month, or if earlier, the day immediately before the day of the next annual meeting of stockholders."}],"balance_after":20200,"derivative":{"exercise_price":8.44,"expiration_date":"2034-06-12","underlying":"Common Stock","underlying_shares":20200},"source":{"system":"sec-edgar","filing":"0001415889-24-016949","document":"form4-06142024_080636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924016949/form4-06142024_080636.xml","form_type":"4"}},{"id":1488567,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-06-06T16:06:22.000Z","date":"2024-06-04","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":164433,"derivative":{"exercise_price":0.99,"expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-015737","document":"form4-06062024_080618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924015737/form4-06062024_080618.xml","form_type":"4"}},{"id":1488566,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2024-06-06T16:06:22.000Z","date":"2024-06-04","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":8.4326,"value":168652.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.17 to $8.87, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":604205,"source":{"system":"sec-edgar","filing":"0001415889-24-015737","document":"form4-06062024_080618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924015737/form4-06062024_080618.xml","form_type":"4"}},{"id":1488565,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2024-06-06T16:06:22.000Z","date":"2024-06-04","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0.99,"value":19800.0,"ownership":{"direct":true},"balance_after":624205,"source":{"system":"sec-edgar","filing":"0001415889-24-015737","document":"form4-06062024_080618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924015737/form4-06062024_080618.xml","form_type":"4"}},{"id":1516079,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":88253,"kind":"person","name":"Randolph Sophia","position":1,"cik":"0001817127","reported_name":"Randolph Sophia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-15T16:30:33.000Z","date":"2024-05-13","kind":"sale","planned":true,"acquired":false,"shares":1797,"price":16.6716,"value":29958.8652,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.47 to $16.94, inclusive."}],"balance_after":330349,"source":{"system":"sec-edgar","filing":"0001415889-24-013237","document":"form4-05152024_080510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817127/000141588924013237/form4-05152024_080510.xml","form_type":"4"}},{"id":1516078,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":88253,"kind":"person","name":"Randolph Sophia","position":1,"cik":"0001817127","reported_name":"Randolph Sophia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-05-15T16:30:33.000Z","date":"2024-05-13","kind":"sale","planned":true,"acquired":false,"shares":10203,"price":15.8169,"value":161379.8307,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 11, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.465 to $16.4602, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4."}],"balance_after":332146,"source":{"system":"sec-edgar","filing":"0001415889-24-013237","document":"form4-05152024_080510.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817127/000141588924013237/form4-05152024_080510.xml","form_type":"4"}},{"id":1523424,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-05-08T17:31:26.000Z","date":"2024-05-06","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":184433,"derivative":{"exercise_price":0.99,"expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-24-012637","document":"form4-05082024_090502.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924012637/form4-05082024_090502.xml","form_type":"4"}},{"id":1523423,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2024-05-08T17:31:26.000Z","date":"2024-05-06","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":15.9167,"value":318334.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.55 to $16.3942, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":604205,"source":{"system":"sec-edgar","filing":"0001415889-24-012637","document":"form4-05082024_090502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924012637/form4-05082024_090502.xml","form_type":"4"}},{"id":1523422,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2024-05-08T17:31:26.000Z","date":"2024-05-06","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0.99,"value":19800.0,"ownership":{"direct":true},"balance_after":624205,"source":{"system":"sec-edgar","filing":"0001415889-24-012637","document":"form4-05082024_090502.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924012637/form4-05082024_090502.xml","form_type":"4"}},{"id":1539249,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-04-18T16:49:23.000Z","date":"2024-04-16","kind":"exercise","planned":true,"acquired":false,"shares":25846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and immediately exercisable."}],"balance_after":204433,"derivative":{"exercise_price":0.99,"expiration_date":"2027-03-30","underlying":"Common Stock","underlying_shares":25846},"source":{"system":"sec-edgar","filing":"0001415889-24-011128","document":"form4-04182024_080417.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924011128/form4-04182024_080417.xml","form_type":"4"}},{"id":1539248,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2024-04-18T16:49:23.000Z","date":"2024-04-16","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":14.2039,"value":710195.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.47, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":604205,"source":{"system":"sec-edgar","filing":"0001415889-24-011128","document":"form4-04182024_080417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924011128/form4-04182024_080417.xml","form_type":"4"}},{"id":1539247,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2024-04-18T16:49:23.000Z","date":"2024-04-16","kind":"exercise","planned":true,"acquired":true,"shares":25846,"price":0.99,"value":25587.54,"ownership":{"direct":true},"balance_after":654205,"source":{"system":"sec-edgar","filing":"0001415889-24-011128","document":"form4-04182024_080417.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924011128/form4-04182024_080417.xml","form_type":"4"}},{"id":1546837,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Common Stock","published_at":"2024-04-05T17:37:30.000Z","date":"2024-04-04","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":11.1518,"value":223036.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 6, 2023."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.86 to $11.275, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price."}],"balance_after":628359,"source":{"system":"sec-edgar","filing":"0001415889-24-010443","document":"form4-04052024_090425.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924010443/form4-04052024_090425.xml","form_type":"4"}},{"id":1572540,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-03-18T20:06:28.000Z","date":"2024-03-14","kind":"purchase","planned":false,"acquired":true,"shares":4400,"price":11.3117,"value":49771.48,"ownership":{"direct":true},"balance_after":171620,"source":{"system":"sec-edgar","filing":"0001415889-24-008260","document":"form4-03182024_080318.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924008260/form4-03182024_080318.xml","form_type":"4"}},{"id":1638473,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-16T23:24:14.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024."}],"balance_after":35000,"derivative":{"exercise_price":15.84,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001415889-24-004233","document":"form4-02162024_110202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924004233/form4-02162024_110202.xml","form_type":"4"}},{"id":1638472,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22279,"kind":"person","name":"Wong Shelly","position":1,"cik":"0001857740","reported_name":"Pinto Shelly","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, FINANCE AND CAO"}}],"security":"Common Stock","published_at":"2024-02-16T23:24:14.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024."}],"balance_after":93591,"source":{"system":"sec-edgar","filing":"0001415889-24-004233","document":"form4-02162024_110202.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924004233/form4-02162024_110202.xml","form_type":"4"}},{"id":1638471,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-16T23:21:00.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024."}],"balance_after":80000,"derivative":{"exercise_price":15.84,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001415889-24-004231","document":"form4-02162024_110247.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924004231/form4-02162024_110247.xml","form_type":"4"}},{"id":1638470,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":75468,"kind":"person","name":"GARCIA PETER S","position":1,"cik":"0001188956","reported_name":"GARCIA PETER S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-16T23:21:00.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024."}],"balance_after":110348,"source":{"system":"sec-edgar","filing":"0001415889-24-004231","document":"form4-02162024_110247.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924004231/form4-02162024_110247.xml","form_type":"4"}},{"id":1638469,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Employee Stock Option","published_at":"2024-02-16T23:03:55.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":190000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024."}],"balance_after":190000,"derivative":{"exercise_price":15.84,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":190000},"source":{"system":"sec-edgar","filing":"0001415889-24-004210","document":"form4-02162024_110246.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924004210/form4-02162024_110246.xml","form_type":"4"}},{"id":1638468,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":22280,"kind":"person","name":"Lettmann Jason","position":1,"cik":"0001688269","reported_name":"Lettmann Jason","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Common Stock","published_at":"2024-02-16T23:03:55.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024."}],"balance_after":167220,"source":{"system":"sec-edgar","filing":"0001415889-24-004210","document":"form4-02162024_110246.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1810182/000141588924004210/form4-02162024_110246.xml","form_type":"4"}},{"id":1638481,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":88253,"kind":"person","name":"Randolph Sophia","position":1,"cik":"0001817127","reported_name":"Randolph Sophia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-16T18:17:48.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024."}],"balance_after":95000,"derivative":{"exercise_price":15.84,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001415889-24-004227","document":"form4-02162024_110240.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817127/000141588924004227/form4-02162024_110240.xml","form_type":"4"}},{"id":1638480,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":88253,"kind":"person","name":"Randolph Sophia","position":1,"cik":"0001817127","reported_name":"Randolph Sophia","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-16T18:17:48.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024."}],"balance_after":342349,"source":{"system":"sec-edgar","filing":"0001415889-24-004227","document":"form4-02162024_110240.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817127/000141588924004227/form4-02162024_110240.xml","form_type":"4"}},{"id":1638479,"issuer":{"id":6040,"kind":"organization","name":"ALX ONCOLOGY HOLDINGS INC"},"owners":[{"id":82914,"kind":"person","name":"Pons Jaume","position":1,"cik":"0001816977","reported_name":"Pons Jaume","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"PRESIDENT & CSO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-16T18:09:38.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024."}],"balance_after":95000,"derivative":{"exercise_price":15.84,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0001415889-24-004218","document":"form4-02162024_110225.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1816977/000141588924004218/form4-02162024_110225.xml","form_type":"4"}}],"next_cursor":"2024-02-16T18:09:38.000000Z,1638479"}